Powered by CyTOF® technology

Mass Cytometry for Precision Medicine | Petter Brodin, MD, PhD

Petter Brodin, MD, PhD, discusses how he is implementing the new, high-throughput CyTOF® XT high-dimensional cytometer to advance his latest scientific projects.

"We are building a body of knowledge about the immune system, particularly in early childhood development, that we believe will have broad implications in future health care decision making. Mass cytometry has enabled us to conduct significant immunological research in recent years that has yielded insights that inform new therapies.

We acquired the CyTOF XT™ to expand our capabilities in this regard, providing rich data to help us better understand the incredibly complex human immune system, with advancements in throughput, automation and time to results"

Petter Brodin, MD, PhD
Associate Professor of Immunology, Imperial College London, Karolinska Institute
Director, SciLifeLab Mass Cytometry Facility